Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Devereux

Showing results (1-10 of 525) with videos related to

Pageof 53
Sort By:
Current Medical Research and Opinion|February 10, 2007
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) studyRichard B Devereux, Björn Dahlöf
Journal of the American College of Cardiology|March 5, 2020
Aortic Dissection Risk in Marfan SyndromeMary J Roman, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|November 3, 2010
Method errors or unexplained biological information?Giovanni de Simone, Richard B Devereux
American Journal of Hypertension|May 2, 2006
Regression of left ventricular hypertrophy: lodestar to stroke prevention in the treatment of hypertension?Jorge R Kizer, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|April 23, 2003
What is bright is not always goldGiovanni de Simone, Richard B Devereux
Expert Opinion on Pharmacotherapy|October 27, 2004
Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) studyRichard B Devereux, Paulette A Lyle
American Journal of Hypertension|October 31, 2006
Is echocardiography essential in the management of newly diagnosed hypertension?Jonathan N Bella, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|December 26, 2007
Assessing left ventricular performance: a rashomon effectGiovanni de Simone, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|March 26, 2014
Association of central and peripheral blood pressures with intermediate cardiovascular phenotypesMary J Roman, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|April 9, 2008
Questions regarding the aortic measurements of Mitchell et alMary J Roman, Richard B Devereux
Pageof 53

Showing results (1-10 of 525) with videos related to

Sort By:
Pageof 53
Current Medical Research and Opinion|February 10, 2007
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) studyRichard B Devereux, Björn Dahlöf
Journal of the American College of Cardiology|March 5, 2020
Aortic Dissection Risk in Marfan SyndromeMary J Roman, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|November 3, 2010
Method errors or unexplained biological information?Giovanni de Simone, Richard B Devereux
American Journal of Hypertension|May 2, 2006
Regression of left ventricular hypertrophy: lodestar to stroke prevention in the treatment of hypertension?Jorge R Kizer, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|April 23, 2003
What is bright is not always goldGiovanni de Simone, Richard B Devereux
Expert Opinion on Pharmacotherapy|October 27, 2004
Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) studyRichard B Devereux, Paulette A Lyle
American Journal of Hypertension|October 31, 2006
Is echocardiography essential in the management of newly diagnosed hypertension?Jonathan N Bella, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|December 26, 2007
Assessing left ventricular performance: a rashomon effectGiovanni de Simone, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|March 26, 2014
Association of central and peripheral blood pressures with intermediate cardiovascular phenotypesMary J Roman, Richard B Devereux
Hypertension (Dallas, Tex. : 1979)|April 9, 2008
Questions regarding the aortic measurements of Mitchell et alMary J Roman, Richard B Devereux
Pageof 53